Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2003
09/25/2003US20030181445 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders
09/25/2003US20030181440 Isonipecotamides for the treatment of integrin-mediated disorders
09/25/2003US20030181420 Modulators of LXR
09/25/2003CA2518626A1 An improved method for synthesising templated molecules
09/25/2003CA2479481A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478653A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003CA2478540A1 Indazoles substituted with an anti-cancerous activity
09/25/2003CA2478331A1 Peptide deformylase inhibitors
09/25/2003CA2477906A1 Process for making chiral 1,4-disubstituted piperazines
09/25/2003CA2477886A1 Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
09/24/2003EP1346988A1 Process for preparing optically active 2,3-dihydro- benzofuran compounds
09/24/2003EP1346985A1 Pyrimidine derivatives and process for preparing the same
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345930A2 Pharmaceutical compounds
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345910A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345905A1 Potassium channel inhibitors
09/24/2003EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1061080B1 Optically active epoxy compound
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0904270B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444579A 2,2-disubstituted 1,3,-dioxolanes as antitussive agents
09/24/2003CN1444578A 1,3-dioxolanes with antitussive activity
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/24/2003CN1122031C Substituted benzocycloheptapyridine derivatives useful for inhibitino of farnesyl protein transferase
09/24/2003CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension
09/23/2003USRE38257 Piperdine derivatives and hypotensives containing the same
09/23/2003US6624317 Taxoid conjugates as antimitotic and antitumor agents
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624160 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003CA2244196C Dihydrobenzofuran compounds useful as anti-inflammatory agents
09/23/2003CA2094191C Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076434A1 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076429A2 Azepane derivatives and their use as atk1 inhibitors
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003076408A2 Indazole derivatives that are activators of soluble guanylate cyclase
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076403A1 1,2-disubstituded-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2003031403A3 Process to produce derivatives from uk-2a derivatives
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176495 HIV Integrase inhibitors
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176481 Novel imidazole derivatives with anti-inflammatory activity
09/18/2003US20030176480 Amide-type triazole compounds
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176461 Aminopiperidines
09/18/2003US20030176460 Piperidine compounds for use as ccr-3 inhibitors
09/18/2003US20030176451 Reacting a heterocyclic-methanesulfonyl substituted-quinazolineamine compound with amine compound
09/18/2003US20030176446 2,2-disubstituted 1,3-dioxolanes as antitussive agents
09/18/2003US20030176438 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2)
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176432 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids
09/18/2003US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases
09/18/2003US20030176400 For therapy of allergic diseases such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis
09/18/2003US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
09/18/2003US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/18/2003US20030176319 N4-acylcytosine-1,3- dioxolane nucleosides for treatment of viral infections
09/18/2003US20030175995 Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
1 ... 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 ... 694